Health Strategy And Policy Institute

Health Strategy And Policy Institute, a foreign government entity based in Hanoi, Vietnam, operates exclusively as a sub-recipient on federal grants, conducting public health research and implementation work in Vietnam under awards administered by the National Institutes of Health and the US Agency for International Development. The vendor holds no prime federal contracts and no prime federal grants; all six awards in the source data span sub-grant relationships with university and nonprofit prime recipients.

HSPI's customer base splits evenly between two federal agencies. The National Heart, Lung, and Blood Institute (part of the National Institutes of Health under the Department of Health and Human Services) and USAID Vietnam each anchor three awards, representing 100% of the source portfolio. HSPI's activity shows episodic engagement rather than sustained volume: one award in 2017, then a gap until three awards in 2023, followed by single awards in 2024 and 2025. Combined obligated dollars across all six awards total $3.3 million.

HSPI performs community-facing implementation research and needs assessment work in urban Vietnamese settings. Recent work includes a sub-award from the University of Massachusetts Medical School (awarded December 2025) to conduct needs assessment and execute a cluster-randomized effectiveness trial testing the HTNCARE-URBAN hypertension intervention across 720 patients in sixteen communities in Hai Phong city, with capacity building for local health workers. Earlier sub-awards from the same university (July 2024, June 2023) covered similar needs assessment and intervention adaptation work under the same program. HSPI also subcontracts to PATH on USAID's Support for Technical Excellence and Private Sector Sustainability in Vietnam (STEPS) program, performing private sector engagement situation assessment and market survey work related to HIV services.

As a foreign government entity in-country, HSPI does not compete for U.S. contracts and does not hold any IDIQs, GWACs, or parent vehicles. The vendor's federal footprint is limited to sub-recipient roles on global health research and development programs routed through university and nonprofit prime recipients.